THE INNOVATIVE MEDICINES INITIATIVE
The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients.
IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe.
IMI is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA.
IMI 11TH CALL LAUNCHED
On 11 December 2013 IMI launched its 11th Call for proposals with topics on osteoarthritis, Alzheimer's, cancer, zoonoses, tools for drug discovery, antimicrobial resistance, & environmental impacts of medicines.
Deadline for applications: 8 April 2014
- 12/03/2014 : RT @SciNav_it: Whenever appropriate and relevant, SciNav links concepts in scientific texts to entries in the @Open_PHACTS Explorer http://…
- 12/03/2014 : RT @EFPIA: TOMORROW - EFPIA launches campaign for Health & Growth. Use #HealthyEU and be part of the conversation http://t.co/07BgzQEaMX
- 12/03/2014 : RT @EFPIA: BLOG - One Month to Go for IMI Call 11 Deadline – Tips for Success http://t.co/FvlaqX9NUn @MagdaEfpia @IMI_JU